AXIM Biotechnologies, Inc. (AXIM)

0.0115 -0.0007 (-6.15%) At close: 03:30PM EDT

AXIM Biotechnologies, Inc.

6191 Cornerstone Court, East
Suite 114
San Diego, CA 92121
United States
858 923 4422
https://www.aximbiotech.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 6

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. John W. Huemoeller II	President, CEO & Director	420k	N/A	1955
Mr. Robert T. Malasek	CFO & Secretary	90k	N/A	1968
Ms. Catalina Valencia J.D.	Co-Founder & CEO of Sapphire Biotech, Inc.	187.5k	N/A	1949
Mr. Kurt Phinney	Chief Operating Officer	N/A	N/A	1973
Dr. Sergei A. Svarovsky M.B.A., Ph.D.	Chief Scientific Officer & Co-Founder of Sapphire Biotech, Inc.	N/A	N/A	N/A
Dr. Douglas Lake Ph.D.	Chief Clinical Officer of Sapphire Biotech, Inc.	N/A	N/A	N/A
Dr. Alim Seit-Nebi Ph.D.	CTO & Co-Founder of Sapphire Biotech, Inc.	N/A	N/A	N/A
Mr. Jeffrey A. Busby	Senior Vice President of Business Development	N/A	N/A	N/A
Dr. Joseph Tauber M.D.	Chief Medical Officer & Chairman of the Medical Advisory Board	N/A	N/A	1957
Dr. Maria J. Gonzalez Moa Ph.D.	Vice President of Product Development - Sapphire Biotech, Inc.	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.

Corporate Governance

AXIM Biotechnologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.